Therapeutic Drug Monitoring of Posaconazole: an Update

Posaconazole is a second-generation triazole agent with a potent and broad antifungal activity. In addition to the oral suspension, a delayed-release tablet and intravenous formulation with improved pharmacokinetic properties have been introduced recently. Due to the large interindividual and intrai...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Curr Fungal Infect Rep
Главные авторы: Dekkers, Bart G. J., Bakker, Martijn, van der Elst, Kim C. M., Sturkenboom, Marieke G. G., Veringa, Anette, Span, Lambert F. R., Alffenaar, Jan-Willem C.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer US 2016
Предметы:
Clinical Mycology Lab Issues (K Lagrou, Section Editor)
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896980/
https://ncbi.nlm.nih.gov/pubmed/27358662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12281-016-0255-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы